SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
-19.4%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$2.07B
AUM Growth
+$2.07B
(-12%)
Cap. Flow
+$173M
Cap. Flow
% of AUM
8.37%
Top 10 Holdings %
Top 10 Hldgs %
48.47%
Holding
98
New
23
Increased
27
Reduced
24
Closed
17
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$48.8M |
| 2 |
SHPG
Shire pic
SHPG
|
$41.4M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$32.5M |
| 4 |
CELG
Celgene Corp
CELG
|
$32.2M |
| 5 |
Amgen
AMGN
|
$26.7M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$57.3M |
| 2 |
Halozyme
HALO
|
$36M |
| 3 |
Thermo Fisher Scientific
TMO
|
$33.5M |
| 4 |
United Therapeutics
UTHR
|
$30.6M |
| 5 |
Merck
MRK
|
$19.7M |
Sector Composition
| 1 | Healthcare | 95.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADPT
26
DELISTED
Adeptus Health Inc.
ADPT
| $24.7M | 1.19% | 444,783 +257,039 | +137% | +$14.3M |
|
|
NXTM
27
DELISTED
NxStage Medical Inc.
NXTM
| $24.7M | 1.19% | 1,647,309 +946,006 | +135% | +$14.2M |
|
28
Acadia Healthcare
ACHC
$2.12B
| $23.1M | 1.12% | 418,805 +259,953 | +164% | +$14.3M |
|
29
UnitedHealth
UNH
$281B
| $22.6M | 1.09% | 175,590 -34,058 | -16% | -$4.39M |
|
|
ADXS
30
DELISTED
Advaxis, Inc.
ADXS
| $19.6M | 0.95% | 2,174,015 +383,300 | +21% | +$3.46M |
|
31
Acadia Pharmaceuticals
ACAD
$4.38B
| $19.3M | 0.93% | +690,700 | New | +$19.3M |
|
|
STJ
32
DELISTED
St Jude Medical
STJ
| $18.4M | 0.89% | 334,584 -62,577 | -16% | -$3.44M |
|
|
SGNT
33
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $18.3M | 0.88% | 1,501,296 +690,934 | +85% | +$8.41M |
|
34
Ionis Pharmaceuticals
IONS
$6.79B
| $17.5M | 0.85% | 433,300 +283,300 | +189% | +$11.5M |
|
35
uniQure
QURE
$896M
| $17M | 0.82% | 1,427,313 +288,800 | +25% | +$3.43M |
|
36
PTC Therapeutics
PTCT
$3.92B
| $16.8M | 0.81% | 2,615,241 +1,028,983 | +65% | +$6.63M |
|
37
Prothena Corp
PRTA
$441M
| $16.4M | 0.79% | +398,100 | New | +$16.4M |
|
|
ISEE
38
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $15.1M | 0.73% | 357,106 +68,200 | +24% | +$2.88M |
|
39
Intuitive Surgical
ISRG
$170B
| $14M | 0.68% | 23,367 -7,663 | -25% | -$4.61M |
|
|
SAGE
40
DELISTED
Sage Therapeutics
SAGE
| $13.5M | 0.65% | +421,084 | New | +$13.5M |
|
|
AIMT
41
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $13.3M | 0.64% | 982,133 | – | – |
|
42
TG Therapeutics
TGTX
$4.65B
| $13M | 0.63% | 1,521,667 | – | – |
|
43
Novo Nordisk
NVO
$251B
| $11.7M | 0.57% | 216,175 -60,900 | -22% | -$3.3M |
|
|
TMH
44
DELISTED
Team Health Holdings Inc
TMH
| $11.2M | 0.54% | +269,000 | New | +$11.2M |
|
|
IMDZ
45
DELISTED
Immune Design Corp.
IMDZ
| $11.1M | 0.54% | 856,867 | – | – |
|
46
Edwards Lifesciences
EW
$47.8B
| $9.75M | 0.47% | 110,541 -139,754 | -56% | -$12.3M |
|
47
Teladoc Health
TDOC
$1.37B
| $9.37M | 0.45% | 975,533 +398,172 | +69% | +$3.82M |
|
48
Novartis
NVS
$245B
| $8.97M | 0.43% | 123,805 -54,600 | -31% | -$3.96M |
|
|
AVXS
49
DELISTED
AveXis, Inc. Common Stock
AVXS
| $8.11M | 0.39% | +297,600 | New | +$8.11M |
|
|
NUVA
50
DELISTED
NuVasive, Inc.
NUVA
| $8.09M | 0.39% | +166,300 | New | +$8.09M |
|